Research Programs

Fundamental basic laboratory, clinical, and population research are the foundation for all of Karmanos Cancer Institute's Research Programs, which are ultimately directed toward the prevention, early detection or treatment of cancer.

Our Programs include: Tumor Biology and Microenvironment (TBM), Molecular Imaging (MI), Molecular Therapeutics (MT) and Population Studies and Disparities Research (PSDR).

The cancer focus is comprehensive, and encompasses etiology, epidemiology, and prevention, early detection (particularly focused on minority populations), basic and translational research, clinical care (based upon multidisciplinary teams) and clinical research (including investigator-initiated and cooperative group clinical trials).

Other Karmanos Programs

The Latest From Karmanos Cancer Institute

News

Izabela Podgorski, Ph.D. awarded 2022 Charles H. Gershenson Distinguished Faculty Fellowship

Izabela Podgorski, Ph.D., professor of Pharmacology at Wayne State University (WSU) and co-leader of the Prostate Cancer Research Team at Barbara ...

Read More

IN THE NEWS: Karmanos Cancer Institute Expands to Ohio

WJR Dick Haefner, host of WJR's HealthWatch with Dick Haefner, sits down with Gerold Bepler, M.D., Ph.D ., president and CEO, Barbara Ann Karmanos...

Read More

The American Cancer Society awards transportation grant to Karmanos Cancer Institute to facilitate access to cancer care

The American Cancer Society (ACS) recently awarded Barbara Ann Karmanos Cancer Institute $15,000 in transportation grant funding to help alleviate...

Read More
News

Eliminating health disparities around multiple myeloma

Listen Now

ACS CAN Michigan Candid Connection

Listen Now

How Multiple Myeloma affects the African American community

Listen Now